Jensen Gordon L
Department of Nutritional Sciences, The Pennsylvania State University, University Park, Pennsylvania 16802, USA.
JPEN J Parenter Enteral Nutr. 2008 Nov-Dec;32(6):656-9. doi: 10.1177/0148607108324585.
Aging is associated with inflammatory chronic conditions such as obesity, cardiovascular disease, insulin resistance, and arthritis. Sarcopenia-muscle loss with aging-is multifactorial with contributing factors that may include loss of alpha-motor neuron input, changes in anabolic hormones, decreased intake of dietary protein, and decline in physical activity. Research findings suggest that sarcopenia is a smoldering inflammatory state driven by cytokines and oxidative stress. Elevated levels of interleukin-6 and C-reactive protein are often detected. Sarcopenic obesity manifests the added inflammatory burden of adiposity and associated adipokines. Potential interventions for sarcopenia include nutritional supplements, physical activity/resistance exercise, caloric restriction, anabolic hormones, anti-inflammatory agents, and antioxidants. A key question is whether sarcopenia is truly a distinct syndrome or a milder form of a cachexia continuum.
衰老与肥胖、心血管疾病、胰岛素抵抗和关节炎等炎症性慢性病有关。肌肉减少症——随着年龄增长而出现的肌肉流失——是多因素导致的,其促成因素可能包括α运动神经元输入的丧失、合成代谢激素的变化、膳食蛋白质摄入量的减少以及身体活动的下降。研究结果表明,肌肉减少症是一种由细胞因子和氧化应激驱动的隐匿性炎症状态。经常检测到白细胞介素-6和C反应蛋白水平升高。肌肉减少性肥胖表现出肥胖和相关脂肪因子带来的额外炎症负担。针对肌肉减少症的潜在干预措施包括营养补充剂、身体活动/抗阻运动、热量限制、合成代谢激素、抗炎药物和抗氧化剂。一个关键问题是,肌肉减少症究竟是一种独特的综合征,还是恶病质连续体的一种较轻形式。